GEODE CAPITAL MANAGEMENT, LLC

Holdings History for Revance Therapeutics, Inc. - COM (RVNC)

Symbol: RVNC on Nasdaq
Investment type: Equity - Shares of Stock
Class: COM

Shares, Excluding Options vs Price

Value, Excluding Options

Holdings date	Weight	Change	Value $	Shares	Change	Activity %	Price	All Holders
9/30/2024	0%	0%	$11.9M	2.29M	-8,311	-0.36%	$5.19	Q3 2024
6/30/2024	0%	+0%	$5.91M	2.3M	+327,127	+16.6%	$2.57	Q2 2024
3/31/2024	0%	+0%	$9.7M	1.97M	+46,417	+2.41%	$4.92	Q1 2024
12/31/2023	0%	+0%	$16.9M	1.92M	+144,144	+8.1%	$8.79	Q4 2023
9/30/2023	0%	+0%	$20.4M	1.78M	+84,767	+5%	$11.47	Q3 2023
6/30/2023	0.01%	+0%	$42.9M	1.7M	+98,996	+6.2%	$25.31	Q2 2023
3/31/2023	0.01%	+0%	$51.4M	1.6M	+62,069	+4.05%	$32.21	Q1 2023
12/31/2022	0%	+0%	$28.3M	1.53M	+151,204	+10.9%	$18.46	Q4 2022
9/30/2022	0.01%	+0%	$37.3M	1.38M	+146,289	+11.8%	$27.00	Q3 2022
6/30/2022	0%	0%	$17.1M	1.24M	-99,239	-7.43%	$13.82	Q2 2022
3/31/2022	0%	+0%	$26.1M	1.34M	+24,111	+1.84%	$19.50	Q1 2022
12/31/2021	0%	+0%	$21.4M	1.31M	+107,692	+8.94%	$16.32	Q4 2021
9/30/2021	0%	+0%	$33.6M	1.2M	+577	+0.05%	$27.86	Q3 2021
6/30/2021	0%	+0%	$35.7M	1.2M	+83,303	+7.43%	$29.64	Q2 2021
3/31/2021	0%	+0%	$31.3M	1.12M	+128,414	+12.9%	$27.95	Q1 2021
12/31/2020	0%	+0%	$28.1M	992K	+51,418	+5.47%	$28.34	Q4 2020
9/30/2020	0%	+0%	$23.6M	941K	+143,224	+18%	$25.14	Q3 2020
6/30/2020	0%	+0%	$19.5M	797K	+73,582	+10.2%	$24.42	Q2 2020
3/31/2020	0%	+0%	$10.7M	724K	+136,718	+23.3%	$14.80	Q1 2020
12/31/2019	0%	+0%	$9.53M	587K	+9,896	+1.71%	$16.23	Q4 2019
9/30/2019	0%	+0%	$7.5M	577K	+16,142	+2.88%	$13.00	Q3 2019
6/30/2019	0%	+0%	$7.28M	561K	+72,767	+14.9%	$12.97	Q2 2019
3/31/2019	0%	+0%	$7.7M	488K	+102,529	+26.6%	$15.76	Q1 2019
12/31/2018	0%	+0%	$7.77M	386K	+48,325	+14.3%	$20.13	Q4 2018
9/30/2018	0%	+0%	$8.39M	337K	+33,404	+11%	$24.85	Q3 2018
6/30/2018	0%	+0%	$8.35M	304K	+41,697	+15.9%	$27.45	Q2 2018
3/31/2018	0%	+0%	$8.08M	262K	+42,831	+19.5%	$30.80	Q1 2018
12/31/2017	0%	+0%	$7.85M	220K	+16,541	+8.15%	$35.75	Q4 2017
9/30/2017	0%	+0%	$5.59M	203K	+11,129	+5.8%	$27.55	Q3 2017
6/30/2017	0%	+0%	$5.07M	192K	+13,456	+7.54%	$26.40	Q2 2017
3/31/2017	0%	+0%	$3.71M	178K	+25,075	+16.4%	$20.80	Q1 2017
12/31/2016	0%	+0%	$3.17M	153K	+5,247	+3.54%	$20.70	Q4 2016
9/30/2016	0%	+0%	$2.4M	148K	+4,656	+3.25%	$16.20	Q3 2016
6/30/2016	0%	+0%	$1.95M	143K	+3,417	+2.44%	$13.60	Q2 2016
3/31/2016	0%	+0%	$2.45M	140K	+11,322	+8.8%	$17.46	Q1 2016
12/31/2015	0%	+0%	$4.4M	129K	+31,815	+32.8%	$34.16	Q4 2015
9/30/2015	0%	+0%	$2.88M	96.9K	+19,680	+25.5%	$29.75	Q3 2015
6/30/2015	0%	+0%	$2.47M	77.2K	+6,451	+9.12%	$31.97	Q2 2015
3/31/2015	0%	+0%	$1.47M	70.8K	+5,868	+9.04%	$20.73	Q1 2015
12/31/2014	0%	+0%	$1.1M	64.9K	+1,773	+2.81%	$16.93	Q4 2014
9/30/2014	0%	+0%	$1.22M	63.1K	+22,182	+54.2%	$19.32	Q3 2014
6/30/2014	0%	+0%	$1.39M	40.9K	+5,806	+16.5%	$33.99	Q2 2014
3/31/2014	0%	+0%	$1.11M	35.1K	+35,143	NEW	$31.47	Q1 2014

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.